Geneesmiddelenbeleid

This procedure is a motion within the Dutch House of Representatives concerning the national policy for pharmaceuticals. It seeks to address the management, accessibility, and regulation of medicines to ensure patient care and public health standards. This affects the healthcare sector, pharmaceutical companies, and patients in the Netherlands by potentially altering how medications are procured or distributed.